Streetbeat News

Earnings

AMZN

BMBL

CRM

GOOG

MSFT

PYPL

SONY

Bumble Inc. plans to lay off over 30% of its workforce, approximately 350 employees, as part of a strategic shift to optimize operations and accelerate its product roadmap. This move is part of a broader trend in the tech sector, with major companies like Alphabet, Amazon, Sony, PayPal, Block, Microsoft, and Salesforce also announcing significant layoffs. Bumble's decision aims to drive stronger operating leverage and align with future strategic priorities, amidst a competitive tech landscape.

Portfolio Pulse from Surbhi Jain

February 28, 2024 | 7:15 pm

BUD

STZ

TAP

Anheuser-Busch InBev SA (NYSE:BUD) is set to report its Q4 earnings with analysts expecting a revenue of $15.50 billion, a slight decline from Q3's $15.57 billion but an increase from last year's $14.67 billion. Earnings per share are anticipated to be 78 cents, down from 86 cents in the previous year. The company aims for a full-year EBITDA growth of 4% to 8%. Analyst ratings are mixed, with a notable downgrade from Exane BNP Paribas and an upgrade from Jefferies. Jim Cramer prefers Constellation Brands (NYSE:STZ) over BUD, citing better growth opportunities. BUD's recovery from a boycott and its marketing strategies, including Super Bowl ads and sports sponsorships, are key points of interest for investors.

Portfolio Pulse from Chris Katje

February 28, 2024 | 7:11 pm

BWXT

BWX Technologies shares are trading higher following the announcement of their Q4 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:11 pm

DIA

QQQ

SPY

UNH

XLU

Stocks fell ahead of the Fed's inflation data release, with UnitedHealth dropping over 4% due to a DOJ antitrust investigation. Bitcoin surged over 7%, nearing its all-time high. The real estate sector outperformed, while major indices and ETFs like SPY, DIA, and QQQ saw declines. Earnings reports drove significant stock movements, with Axon and eBay rising, and Boston Beer falling sharply. Chinese ADRs, including Baidu and Alibaba, also declined following disappointing results.

Portfolio Pulse from Piero Cingari

February 28, 2024 | 7:08 pm

GOVX

Geovax Labs (NASDAQ:GOVX) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with an expected EPS of $-2.78. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows a mixed reaction to past earnings reports, with the stock price fluctuating based on actual EPS outcomes and guidance. Currently, GOVX shares are trading at $2.71, reflecting a 76.12% decrease over the last year, indicating investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:02 pm

LSTA

Lisata Therapeutics (NASDAQ:LSTA) is expected to report a Q4 EPS of $-0.89 on Thursday, 2024-02-29. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. The company's past earnings performance shows a history of beating EPS estimates, which has sometimes led to significant share price movements. Shares were trading at $3.22 as of February 27, with a 5.1% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:02 pm

BMBL

OGEN

VANI

Bumble Inc. shares fell by 11.6% following weak quarterly results, missing both earnings and sales estimates. Other stocks showed significant movement, with Vivani Medical, Adial Pharmaceuticals, and vTv Therapeutics among the top gainers due to positive announcements. Conversely, Oragenics and Integral Ad Science were among the biggest losers, with Oragenics falling after pricing a public offering and Integral Ad Science dropping post-earnings.

Portfolio Pulse from Avi Kapoor

February 28, 2024 | 7:02 pm

TDW

Tidewater (NYSE:TDW) is scheduled to release its quarterly earnings report on February 29, 2024, with analysts expecting an EPS of $0.79. The company's past earnings performance shows a mix of misses and beats, with the last quarter missing EPS estimates by $0.67, leading to a 12.5% drop in share price. Shares are currently trading at $71.9, up 47.34% over the last 52 weeks, indicating a generally positive sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:02 pm

ORGO

Organogenesis Hldgs (NASDAQ:ORGO) is set to release its quarterly earnings report on Thursday, 2024-02-29, with an estimated EPS of $0.01. Historical data shows the company has previously beaten EPS estimates, leading to significant share price movements. Shares are currently trading at $3.58, up 29.41% over the last 52 weeks, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:02 pm

CRDF

Cardiff Oncology (NASDAQ:CRDF) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with analysts expecting an EPS of $-0.28. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares are currently trading at $1.78, up 6.97% over the last 52 weeks. Investors will be keenly watching for not just the earnings outcome but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:01 pm